electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
March 05, 2024 16:05 ET
|
electroCore, Inc.
ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference
October 05, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
electroCore Announces Second Quarter 2023 Financial Results
August 09, 2023 16:05 ET
|
electroCore, Inc.
Record second quarter 2023 net sales of $3.6 million, an increase of approximately 65% over second quarter 2022 Company to host a conference call and webcast today, August 9, 2023 at 4:30 PM EDT ...
UM6P Ventures Invests in Infiuss Health to Improve Clinical Trial Participation and Health Equity in Africa
September 29, 2022 06:00 ET
|
UM6P Ventures (988809)
CASABLANCA, Morocco, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Today, UM6P Ventures announced its investment in Infiuss Health. The startup is developing a decentralized SaaS platform to power remote...